Andersen Tobias Vennervald, Bennedbæk Finn Noe, Pedersen Jens, Rosenørn Marie Røsland, Kiss Katalin, Lelkaitis Giedrius, Andersen Luise, Hegedüs Laszlo, Lomholt Anne Fog, Hahn Christoffer Holst, Hvilsom Gitte Bjørn, Homøe Preben, Todsen Tobias
Department of Otorhinolaryngology and Maxillofacial Surgery, Zealand University Hospital, Køge.
Department of Endocrinology and Metabolism, Copenhagen University Hospital - Herlev Hospital.
Dan Med J. 2022 Jul 21;69(8):A03220165.
Thyroid nodules are very common and constitute an increasing clinical challenge since improved imaging capabilities and utilisation have led to a higher number of incidental findings. Ultrasound-guided fine-needle aspiration biopsy (FNAB) is the standard diagnostic tool in the work-up of thyroid nodules suspected of malignancy. Non-diagnostic results remain common and require repeated FNAB, leading to increased costs and delayed treatment of thyroid diseases, including treatment of thyroid cancer. If cytological diagnoses cannot be achieved, surgery may be warranted, which may potentially lead to overtreatment. Optimisation of the FNAB procedure is therefore essential. Spinal needles with a stylet have been found to lead to fewer non-diagnostic results, but studies on the subject are few.
This is a multicentre, two-arm, randomised clinical trial. Adults with thyroid nodules suspected of malignancy will be included consecutively. A total of 350 patients will be assigned randomly 1:1 to have a FNAB with either a spinal (25G) or a conventional (25G) needle. The primary outcome is the rate of diagnostic cytological samples according to the Bethesda system. Secondary outcomes are patient-experienced pain, complication rate and sensitivity and specificity.
This trial will explore whether FNAB from thyroid nodules employing spinal needles compared with conventional fine needles improves diagnostic results, thereby providing evidence-based recommendations for a future choice of the FNAB needle. Secondary outcomes are patient-experienced pain, complication rate and sensitivity and specificity.
This trial received funding from Erik and Susanna Olesens Fond. The funding source had no influence on trial design, data collection, analysis or publication.
gov Identifier: NCT04879355. Registration date: 07032021; version: 29062022.
甲状腺结节非常常见,并且由于成像能力的提高和应用导致偶然发现的数量增加,这构成了日益严峻的临床挑战。超声引导下细针穿刺活检(FNAB)是疑似恶性甲状腺结节检查中的标准诊断工具。非诊断性结果仍然很常见,需要重复进行FNAB,这会导致成本增加以及甲状腺疾病(包括甲状腺癌治疗)的治疗延迟。如果无法获得细胞学诊断,可能需要进行手术,这可能会导致过度治疗。因此,优化FNAB程序至关重要。已发现带有针芯的脊柱穿刺针可减少非诊断性结果,但关于该主题的研究较少。
这是一项多中心、双臂、随机临床试验。将连续纳入疑似恶性甲状腺结节的成年人。总共350名患者将按1:1随机分配,分别使用脊柱穿刺针(25G)或传统针(25G)进行FNAB。主要结局是根据贝塞斯达系统的诊断性细胞学样本率。次要结局包括患者体验到的疼痛、并发症发生率以及敏感性和特异性。
本试验将探讨与传统细针相比,使用脊柱穿刺针进行甲状腺结节的FNAB是否能改善诊断结果,从而为未来FNAB针的选择提供循证建议。次要结局包括患者体验到的疼痛、并发症发生率以及敏感性和特异性。
本试验获得了埃里克和苏珊娜·奥莱森基金会的资助。资助来源对试验设计、数据收集、分析或发表没有影响。
gov标识符:NCT04879355。注册日期:2021年3月7日;版本:2022年6月29日。